BRIEF published on 12/04/2025 at 07:05, 1 day ago Leonteq AG Completes FRTB Transition and Provides Business Update Business Update Board Changes Leonteq AG 2025 Financial Outlook FRTB Transition
PRESS RELEASE published on 12/04/2025 at 07:00, 1 day ago Press release: Leonteq completes transition to FRTB and publishes business update Leonteq AG completes transition to FRTB and announces business update including expectations of underlying loss for 2025. CEO Christian Spieler comments on progress in client business Business Update Leonteq AG Transition FRTB Underlying Loss
BRIEF published on 08/28/2025 at 07:07, 3 months 8 days ago Leonteq Expands Market Presence with New Leverage Products on BX Swiss Leonteq Market Expansion BX Swiss Exchange-Traded Products Leverage Products
PRESS RELEASE published on 08/28/2025 at 07:02, 3 months 8 days ago Press release: Leonteq expands market presence with leverage products on BX Swiss Leonteq expands market presence with leverage products on BX Swiss, launching over 5,000 products with leading execution quality and strategic growth plans Switzerland Leonteq BX Swiss Market Presence Leverage Products
BRIEF published on 08/20/2025 at 16:35, 3 months 15 days ago Leonteq Shareholders Approve Board Proposals at Extraordinary General Meeting 2025 Shareholders' Meeting Leonteq AG Executive Compensation Board Proposals 2025 EGM
PRESS RELEASE published on 08/20/2025 at 16:30, 3 months 15 days ago Press release: Leonteq publishes voting results of its Extraordinary General Meeting 2025 Leonteq AG shareholders approve all proposals at the Extraordinary General Meeting 2025, including changes to Articles of Association and reduced executive compensation for 2026 Shareholders Voting Results Compensation Extraordinary General Meeting Leonteq AG
BRIEF published on 07/24/2025 at 06:35, 4 months 12 days ago Leonteq Reports Financial Progress in H1 2025 Regulatory Compliance Executive Changes Financial Growth Trading Performance Leonteq Results
PRESS RELEASE published on 07/24/2025 at 06:30, 4 months 12 days ago Press release: Leonteq publishes half-year 2025 results Leonteq publishes half-year 2025 results, reporting 33% increase in profit. Focus on capital ratios & new growth strategy. Eric Finn Schaanning appointed Chief Risk Officer Growth Strategy Leonteq Half-year Results Profit Capital Ratios
BRIEF published on 06/30/2025 at 07:05, 5 months 5 days ago Leonteq Publishes Agenda for 2025 Extraordinary General Meeting Extraordinary General Meeting Leonteq AG Shareholder Engagement Executive Compensation Financial Year 2026
PRESS RELEASE published on 06/30/2025 at 07:00, 5 months 5 days ago Press release: Leonteq publishes agenda for the extraordinary general meeting 2025 Leonteq AG publishes agenda for the extraordinary general meeting 2025, addressing executive compensation for the financial year 2026 in response to shareholder feedback Extraordinary General Meeting Leonteq AG Executive Compensation Shareholder Expectations Strategy Alignment
Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
